Tonix Pharmaceuticals Holding Corp (TNXP)

0.41 -0.03  -6.82% NASDAQ Feb 18, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events


Date Type Description
11/01/2019 Splits Ratio: 1:10
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Aug. 14, 2018
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is focused on delivering an efficacious and safe long-term treatment for PTSD. PTSD is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its product candidate, TNX-102 SL, a proprietary low-dose cyclobenzaprine sublingual tablet, designed for bedtime administration, is in Phase 3 development as a potential treatment for PTSD.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.